Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: Nat Genet. 2015 Jan 12;47(2):164–171. doi: 10.1038/ng.3185

Table 3.

Summary of data on SNPs, closest gene and all genes in 1 MB region for each locus

Loci Position of
top SNP
#
putatively
causal
SNPs
Genes in window of
putatively causal SNPs
# SNPs
aligned w/
biofeatures
Normal
eQTL
closest
gene
Tumour
DNA
copy
number
Significant
expression
difference
in tumour
vs normal
Known
role of
gene
in
cancer
#
Genes
in
1MB
region
Other known
cancer genes in
1MB region
1p36 promoter
region of
WNT4
39 WNT4, CDC42,
LINC00339
11 NS loss Yes 11 RAP1GAP, CDC42
1p34.3 intron 3 of
RSPO1
15 RSPO1 0 NS gain Yes 22 C1orf109, FHL3
4q26 intron 3 of
SYNPO2
4 SYNPO2 2 NS** loss down Yes 12 none
6p22.1 intron 1 of
GPX6
22 GPX6, GPX5 1 N/A gain 23 ZKSCAN3, TRIM27
9q34.2 4.3kb
upstream of
ABO
18 ABO, SLC2A6* 1 NS loss down Yes 32 TSC1, RALGDS,
RPL7A, VAV2
17q11.2 intron 6 of
ATAD5
16 ATAD5, TEFM, ADAP2,
CRLF3, SUZ12P1
0 NS loss up Yes 17 NF1

Proximal promoter regions were defined as 1kb upstream of the transcription start site

N/A indicated no expression of GPX6 in normal tissues. NS, not significant.

Biofeatures defined as open chromatin, H3K4me3 or H3K27ac marks detected in normal ovarian and/or fallopian cells

*

There are 16 genes in this region; ABO, SURF6, MED22, RPL7A, SNORD24, SNORD36B, SNORD36A, SNORD36C, SURF1, SURF2, SURF4, C9orf96, REXO4, ADAMTS13, CACFD1, SLC2A6, however all SNPs are within or upstream of ABO or upstream of SLC2A6.

**

Trend p=0.067